Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded revision: v3.4.3 and removed revision: v3.4.2.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page adds Revision: v3.4.2 and removes the funding-lapse notice along with the prior Revision: v3.4.1.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedShow glossary feature added; capitalization tweaks for update-related labels and a new revision indicator (v3.4.0) were introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). Core study information remains unchanged.SummaryDifference0.0%

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.